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Abstract 
Background: Maintenance of genome stability is critical in human cells. Mutations in or loss of genome stability 
pathways can lead to a number of pathologies including cancer. hSSB1 is a critical DNA repair protein functioning 
in the repair and signalling of stalled DNA replication forks, double strand DNA breaks and oxidised DNA lesions. 
The BLM helicase is central to the repair of both collapsed DNA replication forks and double strand DNA breaks by 
homologous recombination.
Results: In this study, we demonstrate that hSSB1 and BLM helicase form a complex in cells and the interaction is 
altered in response to ionising radiation (IR). BLM and hSSB1 also co-localised at nuclear foci following IR-induced 
double strand breaks and stalled replication forks. We show that hSSB1 depleted cells contain less BLM protein and 
that this deficiency is due to proteasome mediated degradation of BLM. Consequently, there is a defect in recruitment 
of BLM to chromatin in response to ionising radiation-induced DSBs and to hydroxyurea-induced stalled and col-
lapsed replication forks.
Conclusions: Our data highlights that BLM helicase and hSSB1 function in a dynamic complex in cells and that this 
complex is likely required for BLM protein stability and function.
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Background
The maintenance of genome stability is an essential 
requirement for cellular homeostasis. The detection and 
repair of DNA damages is an important aspect of this 
process and is facilitated by proteins that comprise a 
number of distinct, while over-lapping, enzymatic repair 
pathways [1].
Homologous recombination (HR) is a major DNA 
repair pathway that may be employed for the repair of 
double-strand DNA breaks (DSBs) during S and G2 of 
the cell cycle [2]. Here, 5′ DSB ends are resected to gen-
erate long stretches of single-stranded DNA (ssDNA). 
These ssDNA strands may subsequently invade a sister 
chromatid, guided by Rad51, where they are extended via 
complementarity [3]. Second-end capture then allows the 
invading strand to re-anneal with the non-invading DSB 
end, leaving two interlaced sister chromatids [4]. Enzy-
matic processing of the intervening junctions (Holliday 
junctions) subsequently yields two intact dsDNA strands. 
HR can also be used for the repair of stalled and collapsed 
replication forks [5, 6]. In these cases, the Rad51-nucle-
ated ssDNA strand is generated either by resection of the 
‘one-ended’ DSB formed by fork collapse [7], or from the 
nascent leading strand of an otherwise intact, although 
stalled, replication fork [6]. The nucleated strand can 
then re-invade the same chromatid and replication can 
continue without need for second-end capture [5, 6].
The remodelling of duplex DNA, as well as the migra-
tion of fork and Holliday junctions, is a central require-
ment of HR and is achieved by a number of DNA 
helicases. Bloom syndrome protein (BLM), a member 
of the RecQ family of helicases, is one such enzyme, 
with roles in HR, as well as telomere maintenance and 
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replication [8, 9]. The enzymatic activity of BLM is 
achieved through its evolutionarily conserved helicase 
domain, a feature it shares in humans with the related 
helicases WRN, RECQ4, RECQ1 and RECQ5β [10]. 
During the initiation of HR, BLM associates with the 
Mre11–Rad50–Nbs1 (MRN) complex and with either the 
Exo1 or CtIP nucleases to promote end resection and the 
generation of an invading ssDNA strand [9]. In addition, 
BLM is required for the dissolution of double Holliday 
junctions, during the later stages of HR [11]. Here, BLM 
is able to converge both Holliday junctions into a hemi-
catenane structure, which is subsequently cleaved by its 
binding partner TOPIIIα, generating two non-crossover 
products [11]. BLM is also thought to be required for the 
restart of stalled replication forks, where it is proposed 
to stimulate fork regression and Holliday junction forma-
tion [12]. This activity may result in the displacement of 
the nascent leading strand, generating a stretch of ssDNA 
that could subsequently be used for strand invasion [13].
Single-stranded DNA-binding (SSB) proteins are addi-
tional fundamental components of DNA repair pathways 
[14]. These can be subdivided into the “simple SSBs”, 
which are composed of one polypeptide, as well as the 
higher-order “replication protein A (RPA)”-like SSBs 
[15]. RPA is the most studied SSB family member in 
humans and is a central factor in many DNA repair pro-
cesses [14–17]. Humans also encode a number of simple 
SSBs, including the more recently described human sin-
gle-stranded DNA-binding protein 1 (hSSB1) [18]. hSSB1 
has previously been found to function in HR-mediated 
DSB repair, where it is involved in the initial detection 
of lesions, as well as the stimulation of end-resection by 
MRN and Exo1 [19–21]. hSSB1 also has described roles 
in the response to replication disruption and promotes 
replication fork restart following polymerase inhibition 
[22].
In this study we demonstrate that in addition to these 
roles, hSSB1 can form a dynamic complex with BLM. 
Loss of hSSB1 results in a decreased stability of BLM 
polypeptide and consequently a failure in BLM accumu-
lation at sites of DNA damage and stalled replication.
Methods
Cell culture and treatments
U2OS and HeLa cell lines were obtained from Sigma-
Aldrich, European Collection of Authenticated Cell 
Cultures and were maintained at 37  °C in Roswell Park 
Memorial Institute (RPMI) medium supplemented with 
10% fetal bovine serum. For ionising radiation treatment, 
cells were exposed to 6  Gy of gamma radiation gener-
ated from a cesium-source irradiator (Gammacell 40 
Exactor) and were harvested at the indicated time points 
after treatment. Camptothecin (1  μM; Sigma-Aldrich) 
was added to the culture media and cells were incubated 
for 4  h. Hydroxyurea (HU; 2  mM; Sigma-Aldrich) was 
added to the culture media and cells were incubated as 
indicated after which cells were harvested for immuno-
blotting or fixed for immunofluorescence. For inhibition 
of the proteasome, cells were grown in RPMI supple-
mented with 10 μM MG132 (SelleckChem) as indicated. 
Cycloheximide (CHX) (2  mg/ml; Sigma-Aldrich) was 
added to the culture media to inhibit protein synthesis 
for the time indicated.
siRNA and plasmid transfections
Stealth small interfering RNA (siRNA) (Thermo-Fisher) 5′-G 
CCCUUCCAGCAACCCUGUUAGUAA-3 and esiRNA 
(Sigma-Aldrich) were used as indicated to transiently 
deplete hSSB1. Transfection of siRNA was carried out 
using Lipofectamine RNAiMax (Thermo-Fisher) at a final 
concentration of 40 nM for stealth siRNA and 20 nM for 
esiRNA. Subsequent treatments were performed at 72 h 
post siRNA transfection.
WT and F98A 3×  FLAG hSSB1 plasmids have been 
described previously [23]. HA-tagged siRNA-resistant 
hSSB1 was generated from a previously described siRNA 
resistant 3× FLAG hSSB1 construct [24] by site directed 
mutagenesis, which was performed using a described 
methodology [25] and the following primers: (F) 5-TACC 
CATACGATGTTCCAGATTACGCTGCGATCGCCAT 
GACGACGGAGACC-3′, (R) 5′AGCGTAATCTGGAAC 
ATCGTATGGGTACATGGTGGCAGATCTCCTCGG 
TACCGG-3′. For the rescue experiment, HA-tagged 
siRNA-resistant hSSB1 was transiently transfected into 
cells that had previously been depleted of endogenous 
hSSB1. Plasmids were transfected using Fugene HD (Pro-
mega) transfection reagent.
Real time qPCR
For real time quantitative RT-PCR, RNA was isolated 
using the RNeasy kit (Qiagen) and 1 μg of RNA was used 
for cDNA synthesis using the RTPCR kit (Thermo-Fisher). 
qRTPCR was performed using the ViiA7 system (ABI). 
The primers used were as follows: BLM FWD 5′-GCAG 
CGATGTGATTTGCATC-3′, BLM REV 5′-ATTCAGCT 
TCTTCCAAATTCTTCTT-3′, hSSB1 FWD 5′-AGCCAA 
ACCCAGAGTACAGC-3′, hSSB1 REV 5′- CTGGTTCTC 
AGAGGCTGGAG-3′, 7SL FWD 5′-ATCGGGTGTCCGC 
ACTAAGTT-3′, 7SL REV 5′-CAGCACGGGAGTTTTG 
ACCT-3′.
Cell lysis, immunoblotting and antibodies
HeLa and U2OS whole cell lysates were prepared by 
resuspension of cells in radioimmunoprecipitation 
(RIPA) buffer, followed by sonication as described previ-
ously [24]. Samples were then electrophoresed on 4–12% 
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Bis–Tris Plus Bolt precast gels (Thermo-Fisher) and pro-
teins transferred onto nitrocellulose membranes prior to 
incubation with primary antibodies.
The hSSB1 antibody was purified from sheep anti-
serum as described previously [18]. Rabbit and goat anti-
bodies against BLM were purchased from Bethyl (cat# 
A310-029A) and used for immunoprecipitation and west-
ern blotting. A BLM antibody was also purchased from 
Sigma-Aldrich (cat# HPA005689) and used for immuno-
fluorescence microscopy and western blotting. Commer-
cial antibodies against RPA32 (clone 4E4, cat# 2208), SP1 
(cat# 5931), pS1981 ATM (clone D6H9, cat#5883) and 
pol II CTD (clone 4H8, cat# 2629) were purchased from 
Cell Signaling Technology. MRE11 (cat# HPA002691), H3 
(cat# H0164) and FLAG (clone M2, cat# F1804) antibod-
ies were purchased from Sigma-Aldrich, the actin anti-
body (clone C4, cat# 612656) from BD Biosciences, the 
INTS3 antibody (cat# A302-050) from Bethyl, the PCNA 
antibody (clone PC10; cat# SANTSC-56) from VWR and 
the RPA70 antibody from Oncogene Research Products 
(cat# NA13).
Primary antibodies were detected with fluorescent 
(IRDye 680RD or 800CW) donkey anti-mouse, rabbit, 
goat or rat secondary antibodies (Li-Cor) and visualised 
using an Odyssey Imaging system (Li-Cor). Western blot 
quantification was performed with ImageJ software.
Co‑immunoprecipitation
Cells were resuspended in ice-cold immunoprecipitation 
buffer (20 mM HEPES pH 8, 150 mM KCl, 10 mM  MgCl2, 
0.5 mM EDTA, 0.2% NP40, 0.5 mM DTT, 5% glycerol, 1× 
protease inhibitor cocktail (Roche) and 1× Pierce Uni-
versal Nuclease for cell lysis (Thermo-Fisher) and lysed 
by sonication. Samples were then incubated with mag-
netic protein A/G Dynabeads (Thermo-Fisher) that had 
firstly been incubated with 1 μg of primary antibody per 
mg of cell lysate. Samples were incubated with beads for 
1 h at room-temperature, beads washed five times in PBS 
containing 0.02% Tween 20 and bound proteins eluted in 
loading dye prior to analysis by immunoblotting.
Immunofluorescence microscopy
Cells were grown in optical glass bottom 96 well plates 
(Cellvis). Following IR or HU treatment, cells were pre-
extracted for 5 min in ice-cold extraction buffer (20 mM 
HEPES (pH 8), 20 mM NaCl, 5 mM  MgCl2, 1 mM ATP 
and 0.5% NP40). Cells were then fixed in 4% paraformal-
dehyde in PBS, permeabilised in 0.2% Triton and blocked 
with 5% goat serum. Images were taken on a Deltavision 
PDV microscope and analysed using Image J (FiJi) soft-
ware. Pearson correlation coefficient was measured using 
the Deltavision SoftWoRx software version 6.5.1 (GE 
Healthcare Life Sciences). One-way analysis of variance 
was employed to assess whether a statistically significant 
difference between the mean Pearson correlation coef-
ficient value  (r2) may exist between control and treated 
cells using GraphPad Prism version 6 software. Post hoc 
analysis was then employed to compare the mean  r2 value 
of each treatment group with the mean  r2 value of control 
cells.
Sub‑cellular protein fractionation
Sub-cellular protein fractionation was performed using 
a Pierce subcellular fractionation kit (Thermo-Fisher) as 
per manufacturer’s instructions.
Results
hSSB1 associates with BLM in cells
Human single stranded DNA-binding protein 1 is a cen-
tral cellular component required for the repair of double-
strand breaks by HR, as well as the repair and restart of 
stalled and collapsed DNA replication forks [18, 20–22]. 
Recruitment kinetics of hSSB1 provide evidence for both 
early and late functions in these repair processes [18, 20, 
21]. hSSB1  has been identified in several protein com-
plexes including with MRN, hOGG1, INTS3, Rad51 
and p53 [20, 26–28]. The BLM helicase, like hSSB1, is 
involved in the repair of IR-induced DSBs and the repair 
of stalled DNA replication forks [8, 9, 11]. BLM is also 
known to interact with proteins that contain OB-folds 
such as the trimeric RPA complex [29, 30], RMI1 and 
RMI2 [31, 32], thus we wondered whether BLM might 
also interact with the OB-fold containing protein hSSB1. 
We first investigated the interaction between BLM and 
hSSB1 at various time points post IR treatment by immu-
noprecipitating BLM from U2OS whole cell lysates using 
an anti-BLM antibody. To exclude the possibility that 
DNA or RNA might mediate the interaction, we treated 
the cell lysates with benzonase or universal nuclease 
before performing the co-immunoprecipitation experi-
ments. We consistently found that hSSB1 and BLM were 
present in the same protein complex in cells and that 
the interaction decreased at 1 h post IR and returned 
to basal levels by 3 h post IR (Fig. 1a, c). The reciprocal 
immunoprecipitation with an anti-hSSB1 antibody con-
firmed the interaction, as well as the dynamics of the 
interaction with a decrease in BLM protein in the hSSB1 
complex at 1 h post IR and return to basal levels at 3 h 
post IR (Fig. 1b, c). We also immunoblotted for INTS3, a 
known hSSB1 interactor [26], which confirmed the pres-
ence of INTS3 in the precipitant. Moreover, we did not 
observe a similar decrease in the hSSB1–INTS3 interac-
tion in response to IR treatment, indicating that the dis-
sociation of BLM from the hSSB1 complex is specific to 
BLM. These results suggest that a BLM and hSSB1-con-
taining protein complex exists in untreated cells and that 
Page 4 of 10Croft et al. BMC Molecular Biol  (2017) 18:13 
IR treatment induces an initial dissociation of BLM and 
hSSB1 and re-association at 2–3 h post treatment.
Both hSSB1 and BLM have described roles in the 
restart of stalled DNA replication forks [12, 22]. To inves-
tigate if the interaction between hSSB1 and BLM was 
altered after fork stalling, we treated U2OS cells with 
hydroxyurea (HU) for 6  h and performed immunopre-
cipitation reactions in whole cell lysates. As shown in 
Fig.  1d, we did not observe a significant change in the 
interaction between BLM and hSSB1, suggesting the 
BLM and hSSB1 interaction is not affected by the HU 
treatment at the time point examined. Interestingly, the 
BLM antibody used in the immunoprecipitation detected 
2 bands (Fig. 1a, d) although only one band is associated 
with the hSSB1 complex (Fig. 1b; Additional file 1: Figure 
S1). Further studies are required to verify if these bands 
represent post-translationally modified BLM protein and 
which species of BLM is found in complex with hSSB1.
A large proportion of the cellular hSSB1 pool is pre-
sent in complex with INTS3 [26]. In order to investi-
gate whether the interaction between BLM and hSSB1 
is mediated by INTS3, 3× FLAG-tagged hSSB1 wild 
type (hSSB1–FLAG–WT) and INTS3-binding mutant 
F98A (hSSB1–FLAG–F98A) (decreases hSSB1 binding 
to INTS3 complex; Additional file 1: Figure S2 [23, 33]) 
plasmids were overexpressed in U2OS cells and pro-
tein complexes were immunoprecipitated using an anti-
BLM antibody. As shown in Fig. 1e, both WT and F98A 
mutant hSSB1 were co-immunoprecipitated by the BLM 
antibody to similar levels, however the INTS3 protein 
did not immunoprecipitate to the same degree in the 
cells expressing the hSSB1–F98A mutant, suggesting that 
INTS3 is not required for the hSSB1–BLM interaction. It 
does however demonstrate for the first time that INTS3 
is in complex with BLM and hSSB1 within cells. The 
known BLM binding partners MRE11, RPA70 and RPA32 
were also detected in the BLM complex (Fig. 1e).
We further investigated whether hSSB1 and BLM 
may interact directly using recombinant hSSB1 (E. coli 
expressed) and BLM (Insect cell expressed) proteins. 
However, we were unable to detect a direct interac-
tion between the two proteins (data not shown). Taken 
together, these results suggest that BLM and hSSB1 may 
associate in cells through an indirect means, or may 
require specific post-translational modifications not pre-
sent in the recombinant proteins. Indeed, both hSSB1 
and BLM are known to exist in phosphorylated, ubiquit-
inated and sumoylated (BLM only) forms [8].
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Fig. 1 hSSB1 associates with BLM in cells. BLM (a) or hSSB1 (b)-associating proteins were immunoprecipitated from U2OS whole cell lysates 
prepared from cells that had been either left untreated or exposed to 6 Gy ionising radiation (IR) and harvested after the indicated time periods. 
Control immunoprecipitations with an isotype IgG were performed from combination (c) samples comprised of equal amounts of each sample. 
Eluted proteins and whole cell lysates were separated by electrophoresis and immunoblotted with antibodies against BLM, hSSB1 and INTS3 (b 
only). hSSB1 (a) or BLM (b) levels were determined by densitometry, normalised to the levels of BLM (a) or hSSB1 (b) as well as to the level of input 
protein and expressed relative to the untreated lane. c Line graph illustrating hSSB1: BLM association from three independent repeats of a and 
b. d BLM was immunoprecipitated from whole cell lysates, prepared from U2OS cells that were either untreated or had been treated with 2 mM 
hydroxyurea (HU) for 6 h. Eluted proteins and whole cell lysate samples (input) were immunoblotted with antibodies against BLM and hSSB1. hSSB1 
levels were determined and expressed as per (a). e U2OS cells were transfected with plasmids encoding wild type (WT) or F98A 3× FLAG hSSB1, 
24 h prior to cell lysis and immunoprecipitation of BLM-association proteins. Eluent was immunoblotted with antibodies against BLM, FLAG, INTS3, 
MRE11, RPA70 and RPA32. FLAG levels were determined by densitometry and normalised to the levels of BLM
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hSSB1‑positive chromatin structures partially overlap 
with BLM‑positive chromatin structures following IR‑ 
and HU‑ induced DNA damage
Human single stranded DNA-binding protein1 and 
BLM have been shown to re-locate to chromatin in cells 
treated with DNA damaging agents and DNA replica-
tion inhibitors [18, 22, 34, 35]. To determine whether 
BLM and hSSB1 relocate to the same chromatin struc-
tures in response to DSB induction, we performed a 
time course following IR treatment in asynchronous 
HeLa cells. Prior to fixation at 0, 1, 3, and 6  h post IR 
treatment (6 Gy) cells were pre-extracted to remove the 
soluble nucleoplasm, leaving only the insoluble chro-
matin bound proteins to be immunostained and visual-
ised. As expected, both BLM and hSSB1 showed a large 
increase in chromatin localisation following IR treat-
ment, with a partial overlap between hSSB1- and BLM- 
positive fluorescence staining (Fig. 2a). Measurement of 
the Pearson correlation coefficient  (r2) determined that 
the overlap between BLM- and hSSB1-positive staining 
significantly increased at all time points tested, with a 
peak at 3 h post IR (Fig. 2b).
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Fig. 2 hSSB1 co-localises with BLM at IR- and HU-induced nuclear foci. a, c HeLa cells were pre-extracted prior to fixation, 0, 1, 3, 4.5 and 6 h post 
ionising radiation (IR) treatment (a) or 0, 4 and 20 h post treatment with hydroxyurea (HU) as indicated (c). Fixed cells were incubated with primary 
antibodies against BLM, hSSB1 and PCNA (c only), which were detected with fluorescent secondary antibodies and visualised using a DeltaVision 
PDV microscope. Co-localisation of BLM and hSSB1 is demonstrated by the merged image (merge) and by the analysis of images using the Image J 
colocalisation plugin showing only the colocalised pixels (colocalisation). DAPI was used to stain the nuclei. b, d Box and Whisker plots representing 
Pearson correlation coefficient  (r2) from 24 (for a) and 15 (for c) individual cells for each time-point from a and c. One-way Anova followed by post 
hoc analysis was used to assess the statistical significance between the mean  r2 values of each treatment group and untreated cells. ****p < 0.0001
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We also investigated the localisation of BLM and hSSB1 
following replication stress. HeLa cells were treated with 
HU for 4 h to induce mostly stalled replication forks and 
for 20 h to induce stalled and collapsed replication forks 
[6]. Prior to fixation, cells were extracted to remove the 
soluble nucleoplasm. To identify S-phase cells, PCNA 
was used as a marker. As expected, we observed an 
increase in BLM and hSSB1 chromatin localisation post 
both 4 and 20 h of HU treatment (Fig. 2c), with a signifi-
cant increase in overlap between hSSB1- and BLM-posi-
tive staining at both time points (Fig. 2d).
The partial overlap between hSSB1 and BLM at IR- and 
HU- induced chromatin structures may represent dif-
ferent sub-compartments within one repair centre or a 
snapshot of the temporally dynamic composition of these 
chromatin structures [36], which is consistent with their 
roles in the unwinding of the DNA (BLM) and coating of 
the single stranded DNA (hSSB1) during the repair pro-
cess. Taken together, these results suggest that although 
BLM and hSSB1 are part of the same DNA repair com-
plex they may function at different sites or stages in the 
DSB repair process and in the restart and repair of stalled 
and collapsed replication forks.
hSSB1 is required for recruitment of BLM to chromatin 
in response to DNA damage
We and others have shown that in response to DSB for-
mation, hSSB1 is required for both activation of signal-
ling and proper recruitment of repair proteins at these 
sites [18, 19, 21, 37]. We therefore investigated whether 
hSSB1 depletion may affect BLM recruitment to chro-
matin in response to DNA damaging agents and replica-
tion stress using subcellular fractionation to separate the 
nuclear components. U2OS cells transfected with control 
or hSSB1-targeting esiRNA (Sigma-Aldrich) were irra-
diated to cause DSBs and harvested 4 h post treatment. 
As expected, BLM was found to load onto chromatin fol-
lowing IR treatment in control siRNA transfected cells 
(Fig. 3a). In contrast, in hSSB1-depleted cells, BLM chro-
matin loading was consistently reduced at 4  h and 3  h 
post IR treatment (Fig.  3a; Additional file  1: Figure S3). 
Moreover, we also observed consistently reduced lev-
els of BLM chromatin loading in the nuclease-resistant 
chromatin fraction (Fig.  3b) and reduced protein levels 
in the soluble nuclear fraction (Fig.  3c), suggesting that 
hSSB1 may regulate BLM protein levels in the soluble 
nuclear fraction, consequently also affecting its recruit-
ment to chromatin.
We have recently shown that hSSB1 is also required 
for recruitment of DNA repair proteins to collapsed 
replication forks [22]. Consistent with its roles in HR 
and DNA replication, BLM expression is highest during 
S/G2 cell cycle phases [38, 39], we hence investigated 
whether hSSB1 depletion may also affect BLM protein 
levels and recruitment to chromatin in response to rep-
lication stress, in the different nuclear compartments. 
HeLa cells transfected with control or hSSB1 target-
ing stealth siRNA (Thermo-Fisher) were treated with 
HU (2 mM) for 20 h to induce replication fork collapse 
or with camptothecin (CPT; 1 μM) for 3 h to cause rep-
lication-induced DSBs. As expected, BLM was found 
to load onto chromatin (tenfold and 3.6 fold increase, 
respectively) following HU and CPT treatment in control 
siRNA transfected cells (Fig. 3d). In contrast, in hSSB1-
depleted cells, BLM chromatin loading was slightly, but 
reproducibly reduced following HU and CPT treat-
ment (eightfold and 2.2 fold increase, respectively). Fol-
lowing HU treatment, RPA is phosphorylated on Ser 33 
and this facilitates the response of replication forks to 
replication stress [40]. We also observed that loading of 
RPA70, RPA32 and phosphorylation of RPA32 at serine 
33 (S33) were reduced in hSSB1 depleted cells (Fig. 3d). 
In the nuclease resistant chromatin fraction, two BLM 
bands were detected and although both bands showed 
decreased chromatin loading in hSSB1 depleted cells, a 
more pronounced defect was observed for the top band 
(Fig.  3e). Moreover, soluble nuclear levels of BLM were 
decreased in hSSB1-depleted cells to half the amount of 
control cells, and a lack of BLM protein stabilisation in 
response to HU treatment was also evident in hSSB1-
depleted cells (Fig. 3f ). Similarly, RPA 70 and RPA 32 pro-
tein levels were also decreased following hSSB1 depletion 
(Fig. 3f ). The defect in BLM chromatin recruitment fol-
lowing HU treatment in absence of hSSB1 was detected 
in both HeLa and U2OS cells (Additional file  1: Figure 
S4). Consistent with this BLM defect in the nuclear frac-
tions, total BLM protein levels were reduce by  ~50% in 
hSSB1 depleted HeLa cells compared to control cells 
(Fig.  3g; Additional file  1: Figure S5). Collectively, these 
results suggest that hSSB1 may regulate the total cellu-
lar pool of BLM, affecting its recruitment to chromatin 
in response to IR-induced DSBs, replication fork collapse 
and replication-induced DSBs.
hSSB1 protects BLM from proteasomal degradation
To further confirm our data, we performed rescue exper-
iments using a siRNA-resistant, HA-tagged hSSB1 con-
struct (HA-hSSB1). 48  h post hSSB1-targeting siRNA 
transfection, U2OS cells were transfected with the HA-
hSSB1 plasmid and harvested 48  h later. Importantly, 
ectopic expression of hSSB1 was able to rescue BLM pro-
tein levels to near-basal levels (Fig. 4a; Additional file 1: 
Figure S6), indicating that BLM depletion was not due to 
siRNA off-target effects. Based on these findings we rea-
soned that hSSB1 could regulate BLM helicase by at least 
two mechanisms: by regulating BLM transcript, (indeed 
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hSSB1 has recently been shown to be involved in regula-
tion of transcription termination [41]), or by regulating 
BLM protein stability.
To address whether hSSB1 may affect BLM transcript 
levels, we performed real time quantitative PCR in U2OS 
cells depleted of hSSB1 using stealth and esiRNA. As 
shown in Fig. 4b, the average of three independent exper-
iments, a slight, although not significant upregulation of 
BLM transcripts levels were observed in hSSB1-depleted 
cells compared to control cells, suggesting that the lack 
of BLM protein was not due to reduced levels of BLM 
transcript. The loss of the BLM polypeptide in hSSB1-
depleted cells may therefore reflect a loss of protein 
stability. To investigate whether hSSB1 regulates BLM 
protein stability by preventing its proteasome-mediated 
degradation, we next treated U2OS cells depleted of 
hSSB1 with the proteasome inhibitor MG132. Indeed, 
MG132 treatment restored BLM protein levels in hSSB1-
depleted U2OS cells (Fig. 4c; Additional file 1: Figure S6), 
suggesting that hSSB1 interaction with the BLM complex 
may protect BLM from degradation in cells.
Discussion
BLM is an essential helicase with demonstrated roles in 
HR-mediated DNA repair processes [8, 9, 11]. In this 
study, we have identified a novel association between 
BLM and hSSB1, a single-stranded DNA-binding protein 
also known to promote HR during double-strand DNA 
break repair and stalled replication fork stability and 
repair [14, 18, 22]. Reciprocal co-immunoprecipitation 
experiments suggested that while BLM and hSSB1 asso-
ciate in undamaged cells, the induction of double-strand 
DNA breaks by ionising radiation exposure results in an 
initial dissociation of the hSSB1–BLM complex, prior 
d
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to re-association 2–3  h post treatment. These data may 
suggest that while hSSB1 and BLM form a complex in 
undamaged cells, they may function independently in the 
early stages of HR-mediated DSB repair. This may include 
during end-resection, a process that is facilitated by the 
BLM–DNA2–RPA–MRN and EXO1–BLM–RPA–MRN 
complexes [42]. Indeed, whilst we and others have sug-
gested a role for hSSB1 in the initial stimulation of this 
process [18, 19], our data may suggest that hSSB1 might 
not remain coupled to the BLM-associated end-resection 
machinery subsequent to initial loading. The dissociation 
could also be mediated by post-translational modifica-
tions on both proteins, which could result in changes in 
complex formation.
The observation that hSSB1 and BLM re-associate after 
2–3  h of DSB formation may however suggest a func-
tional role in HR subsequent to end resection. Although 
a role for hSSB1 in later stage HR remains unclear, it 
should be noted that an association with the Rad51 
recombinase, a known interactor of BLM, has been pre-
viously demonstrated [18]. Indeed, our observation of 
increased chromatin co-localisation between hSSB1 and 
BLM 3 and 6  h post-IR exposure support a functional 
relevance of their interaction in HR. It will therefore be 
interesting to establish whether hSSB1 and BLM func-
tion together in the regulation of Rad51-mediated strand 
invasion, as well as in the well-established roles of BLM 
in double Holliday junction dissolution [43].
A similar interaction and co-localisation of hSSB1 and 
BLM was also observed following replication fork dis-
ruption by HU treatment. Although the functional sig-
nificance of this observation also remains unclear, roles 
for both of these proteins in such a response has been 
previously suggested [14, 22, 44–46]. This includes the 
BLM-mediated regression of replication forks and the 
generation of a ssDNA invading strand for HR-mediated 
fork restart by HR [12]. As hSSB1 also has been found 
to promote replication fork restart, the investigation of 
a potential role together in this process may also be of 
future value. The partial co-localisation between BLM 
and hSSB1 at nuclear structures following IR and HU 
treatment may be due to the fact that hSSB1 is involved 
at multiple stages of HR and thus likely to be present in 
chromatin structures that have not yet recruited BLM. 
Thus the duration of time in which hSSB1 and BLM are 
present together at a DSB site may be very short and cer-
tainly requires further investigation in the future.
The exact nature of the BLM: hSSB1 complex also 
remains uncertain. As we were unable to detect a direct 
physical interaction between recombinant BLM and 
hSSB1, it remains probable that other proteins instead 
mediate this association. This may include components 
of the core BLM complex (BLM–TopoIIIα–RPA–RMI1–
RMI2), as well as members of the larger BASC super 
complex, which also includes MSH2, MSH6, MLH1, 
ATM, RFC and the MRN complex [35, 47]. It is indeed 
worth noting that a direct interaction between hSSB1 
and the MRN component MRE11 has been previously 
established, which may represent a plausible intermedi-
ate [20]. Alternatively, we cannot exclude that a direct 
interaction between hSSB1 and BLM may occur in 
human cells, although requires specific post-transla-
tional modifications of BLM or hSSB1 that are not pre-
sent in the recombinant protein. A full dissection of the 
BLM–hSSB1 association will however require additional 
experimentation.
An important observation of this study was the appar-
ent dependence of BLM protein stability on hSSB1. 
Although we cannot conclude on the processes through 
which this occurs, it is noted that BLM levels in hSSB1-
depleted cells were largely restored by proteasome inhibi-
tion with the compound MG-132. It is therefore tempting 
to consider that hSSB1 may promote BLM stabilisa-
tion via its interaction with one of the BLM complexes. 
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plasmid (WT HA hSSB1). Cells were harvested after a further 48 h 
and whole cell lysates immunoblotted with antibodies against BLM, 
hSSB1 and actin. BLM levels were determined by densitometry, nor-
malised to the levels of actin and expressed relative to the untreated 
lane. b U2OS cells were transfected with control or hSSB1-depleting 
siRNA for 72 h. BLM and hSSB1 mRNA levels were determined by 
real time PCR and normalised to the mRNA levels of 7SL. The graph 
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was used to assess statistical significance where p < 0.05 was con-
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Alternatively, hSSB1 may regulate cell signaling pathways 
that affect BLM post translational modifications to pre-
vent its degradation. Indeed, BLM was recently shown to 
be ubiquitinated by the E3 ligase MIB1, and interaction 
between BLM and TopBP1 prevented MIB1–dependent 
degradation of BLM [39]. The interaction between hSSB1 
and BLM may act in a similar manner to prevent BLM 
from proteasome mediated degradation. Interestingly, 
hSSB1 was recently shown to interact with both p53 and 
p21 and protect both proteins from ubiquitin-mediated 
degradation [28, 48]. Taken together, our current find-
ings provide evidence for an additional, indirect means 
through which hSSB1, via regulation of BLM helicase, 
promotes DSB repair and replication fork processing.
Conclusions
The findings described in this work suggest hSSB1 as a 
novel component of BLM complexes. These data thereby 
provide new insight into the regulation of BLM and 
implicate an additional means through which hSSB1 may 
promote genome stability in the cell.
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